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Intervention -Secretory phase endometrial biopsy specimens were taken, with informed consent, as an outpatient procedure.
Main outcome measures -Immunohistochemistry with monoclonal antibody D9B1, was used to assess the production and secretion of an oligosaccharide epitope produced by endometrial gland cells between two and seven days after the luteinising hormone surge. A reflected light measuring system was used to assess the amount of epitope within the gland cells, and in the gland lumen.
Results-In the control group of women, mean reflected light measurements at the cell base and cell apex peaked at three and five days after the luteinising hormone surge respectively, and in the gland lumen the epitope accumulated rapidly from three days, reaching a peak at seven days. In the women with infertility the peaks of epitope at the cell base and cell apex were lower, broader, and delayed in onset, and the build up of epitope in the gland lumen was retarded. The synthesis and secretion of the epitope in the women with infertility was therefore
Introduction
Substantial numbers of patients with unexplained infertility attend infertility clinics, with reported prevalences ranging from 6% to almost 60%.' The hormonal profiles of women with unexplained infertility have been much studied and are often normal, but in contrast, the endometrium has been comparatively unexplored as a factor in infertility. This has been justified by the widespread belief that endometrial morphology provides no more than a simple and faithful reflection of the ovarian cycle. The use of the endometrial biopsy specimen as an index of ovulation has been largely superseded by non-invasive, quantitative, sensitive, endocrine assays, and failure of the endometrium to respond fully to a normal ovarian stimulus has remained hypothetical.
The secretory differentiation of the endometrial epithelium has been characterised by raising monoclonal antibodies to hormonally regulated cell surface and secretory components." The monoclonal antibody D9B1 binds to a peptide associated sialooligosaccharide of the sulphated lactosaminoglycan family, 6 which is secreted by gland cells mainly between three and seven days after the luteinising hormone surge.4 Study of the defective luteal phase has shown that there is a strong correlation between infertility and reduced production of the D9B 1 epitope7; this deficiency may occur against a background of normal secretory differentiation as assessed by conventional histology. On the basis of these and other observations,8 it has been suggested that there might be a group ofwomen with infertility in whom the defect is intrinsic to the endometrium. 7 To test this hypothesis we needed a well documented study group that included a control group of women with normal fertility. We have shown that if normal women of known fertility have endometrial biopsy specimens taken at a time that has been calculated prospectively from the luteinising hormone surge then the structure of the endometrium from two to seven days after this surge varies little between subjects, thus suggesting tight biological control.9 This approach eliminates errors arising from variations in the length of the luteal phase in the normal population.'" In our study we examined secretory phase biopsy specimens that had been taken from a group of 27 women with unexplained infertility and from 44 women with normal fertility, and compared the results from the two groups.
Subjects and methods
Endometrial biopsies were performed as an outpatient procedure on 44 women with normal fertility who were requesting sterilisation or the reversal of sterilisation and on 27 women with unexplained infertility. All had given their informed consent and all were attending the infertility clinic at the Jessop Hospital, Sheffield. The following criteria were used to assess fertility: regular menstrual cycles of 25-35 days, no history of menstrual disorders, previous achievement ofa successful pregnancy, no history ofinfertility, and a normal luteinising hormone peak in the cycle in which the endometrial biopsy was performed. Subjects were excluded if they had taken steroid hormones (including the contraceptive pill) or had used an intrauterine device in the three months before the study.
Infertility was referred to as unexplained if a cause could not be identified after completion of our routine fertility survey as defined by the following criteria: infertility of more than one year's duration, normal regular sexual intercourse, no ejaculatory problems, normal semen analysis as defined by the World Health Organisation," normal regular menstrual cycles of 25-35 days, evidence of ovulation as detected by thermal and endocrinological criteria, normal thyroid function tests, normal plasma prolactin concentrations, and normal laparoscopic findings.
The biopsy specimens were all dated from the luteinising hormone surge, and were taken between two and nine days after this surge. Luteinising hormone and progesterone concentrations were measured by immunoassay. '2 All the biopsy specimens were fixed and embedded in the resin JB4,9 and sections were stained by an indirect immunoperoxidase method using the monoclonal antibody D9B 1. 4 Tissue sections from reference blocks of normal endometrium were processed with each experimental section to serve as controls. The amount of antigen was determined by the ability of the product produced by the immunoperoxidase reaction to reflect light when viewed by incident illumination.4" 3 Two blocks were prepared from specimens taken from each subject and 2. glands were examined on sections from each block. Semiquantitative measurements were taken from the base of each cell, and from the apex of each cell, and from the adjacent gland lumen. Background measurements were taken from nearby stromal tissue, which was unstained, and were subtracted from the experimental values. The resulting values were accumulated for each of the three sites measured in each individual subject. This method allowed direct comparisons of the amounts of immunodeposit between subjects at any one site to be made.
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Comparisons between the cell base and other sites might not have been accurate because the deposit might be in a different physical state at the cell base.' Data were analysed using Student's t test and two way analysis of variance.
Results
The average age of the 44 women with normal fertility was 33 8 years (range 24-39). The average age of the 27 women with unexplained infertility was 33-2 (range 24-40). The median duration of their infertility was five years (range 2-10). Of these patients 19 had primary infertility and eight had secondary infertility. The number of subjects from whom biopsy specimens were taken for each day after the luteinising hormone surge is shown in figure 2 . Figure 1 shows the mean reflected light measurements at the cell base and the cell apex for' the two groups of subjects. In the women with normal fertility measurements at the cell base reached a peak three days after the luteinising hormone surge and measurements at the cell apex peaked at five days. Both values declined thereafter. This was consistent with accumulation of D9B1 epitope in the subnuclear area and its subsequent translocation to the cell apex before secretion. In the gland lumen epitope accumulated rapidly from three days after the luteinising hormone surge to reach a peak at seven days ( fig 2) . In contrast, in the group of women with infertility peaks of epitope concentration at'the cell base and the cell apex were lower, broader, and delayed in onset, and the build up of epitope in the gland lumen was retarded by two days. In the infertile women the values for the cell apex four days after the luteinising hormone surge were significantly lower than those in the women with normal fertility (t=2-68, df=7, p<0 025), and, similarly, the values for the gland lumen six days after the luteinising hormone surge were also significantly lower (t=4 45, df-17, p <0 005). The measurements at the cell base six days after the luteinising hormone surge were significantly higher in the infertile women than in the group with normal fertility (t=3-25, df=17, p<0005) thus suggesting a delay in the temporal progression of the epitope to its discharge into the gland lumen in women with infertility. Table I shows the results of a two way analysis of variance that was performed on the data from the fertile and infertile women at four, five, six, seven, eight, and nine days after the luteinising hormone surge. The reflected light measurements of the basal region of the cell and of the gland lumen showed a significant effect of condition -that is, infertility compared with normal fertility. A significant effect of date (the chronological date of the biopsy specimen, expressed as days from the luteinising hormone surge) was seen in all three regions of the glands examined. In the cell base and apex a significant interaction between condition and date was found -that is, as the menstrual cycle progressed the differences became more pronounced.
Daily salivary progesterone concentrations from two to seven days after the luteinising hormone surge were available for 23 of the 27 women with infertility, and 18 of these had values for each day that were normal (defined as above the fifth percentile value for the group of 44 women with normal fertility).4 Three of them had some values that were below normal and the remaining two had values that were consistently lower than normal. Table II shows the results of a two way analysis of variance that was performed on data from the women with normal fertility and from those women with infertility who had normal concentrations of progesterone at four, five, six, seven, eight, and nine days after the luteinising hormone surge. Date and condition were found to have a highly significant effect on the reflected light measurements obtained from the cell base, but only date has a significant effect in the cell apex. The changes in the gland lumen again reflected the changes in the cell base, with the condition and date having significant effects. The t values previously calculated retained their significance when testing was restricted to the 18 women with normal salivary progesterone concentrations. This analysis showed that the women with infertility who had normal concentrations of progesterone exhibited diminished amounts of the D9B 1 epitope.
There was no significant difference in secretory activity between patients with primary infertility and those with secondary infertility.
Discussion
The development of a molecular probe for analysing endometrial secretory differentiation allows a new approach to be made to the characterisation of normal and defective endometrial function.i 47 Our results were consistent with reduced and delayed secretion of the D9B 1 epitope in infertility. Moreover, because the concentrations ofcirculating progesterone were normal in most of the women in this group the data provided evidence to show that the response of the endometrium to a normal ovarian stimulus had been retarded. The average ages of the women with normal fertility and of those with unexplained infertility were comparable and therefore age could be excluded as a factor that might have influenced secretory activity. Abnormality of D9B 1 production occurred in women with primary infertility and in those with secondary infertility, and hence the difference in secretory behaviour that was seen between the women with normal fertility and the women with infertility did not seem to be due to a nonspecific effect of a previous pregnancy.
The function of the glycoprotein carrying the D9B 1 epitope is unknown. Its temporal distribution in the endometria of women with normal fertility has been shown to coincide with the peri-implantation period.4 Our data have shown that it provides a positive diagnostic feature in unexplained infertility, which hitherto has been dependent on the exclusion of all other known causes of infertility.
In summary, our results have shown an endometrial BMJ VOLUME 300 abnormality that is associated with unexplained infertility and which is not due to low concentrations of circulating progesterone. Design-Randomised controlled trial. Allocation to chiropractic or hospital management by minimisation to establish groups for analysis of results according to initial referral clinic, length of current episode, history, and severity of back pain. Patients were followed up for up to two years.
Setting-Chiropractic and hospital outpatient clinics in 11 centres.
Patients-741 Patients aged 18-65 who had no contraindications to manipulation and who had not been treated within the past month.
Interventions-Treatment at the discretion of the chiropractors, who used chiropractic manipulation in most patients, or of the hospital staff, who most commonly used Maitland mobilisation or manipulation, or both.
Main outcome measures-Changes in the score on the Oswestry pain disability questionnaire and in the results of tests of straight leg raising and lumbar flexion.
Results-Chiropractic treatment was more effective than hospital outpatient management, mainly for patients with chronic or severe back pain. A benefit of about 7% points on the Oswestry scale was seen at two years. The benefit of chiropractic treatment became more evident throughout the follow up period. Secondary outcome measures also showed that chiropractic was more beneficial.
Conclusions-For patients with low back pain in whom manipulation is not contraindicated chiropractic almost certainly confers worthwhile, long term benefit in comparison with hospital outpatient management. The benefit is seen mainly in those with chronic or severe pain. Introducing chiropractic into NHS practice should be considered.
Introduction
The high incidence of back pain, its chronic and recurrent nature in many patients, and its contribution as a main cause of absence from work are well known. 
